Editorial on the Research Topic
State of the art body composition profiling: Advances in imaging modalities and patient outcomesIn the last years, body composition (BC) analysis has emerged as a ground-breaking tool that can provide helpful data about nutritional status, in addition to more conventional indicators, as albumin value and body mass index. Recent data disclosed that distinct patterns of BC are associated with different outcomes, in particular in oncologic patients (1).Anomalies of skeletal musclefrequently found in oncologic patients -are related to poor outcomes with higher morbidity and mortality rates. Moreover, the distribution and radiodensity of subcutaneous and visceral adipose tissue emerged as determinant prognostic factor for oncologic outcome. Nevertheless, BC assessment is not yet a standard tool of the routine workup of oncologic patients. This is likely due to the heterogeneity of available data, to the shortage of prospective studies and systematic reviews, to the absence of standardized assessment methods, and to the variation of BC among different populations (2).Hence, we proposed this research topic, on one side, to expand knowledge about the imaging techniques to evaluate BC assessment, ranging from the most conventional ones to the most advanced (including artificial intelligence-aided techniques) (3-5); on the other, to assess the effects of BC on different outcome indicators, as post-operative or chemotherapy-related complications and survival.In our research topic, we published eight papers: 3 focused on liver diseases, 1 on pancreatic cancer, 1 on ovarian cancer, 1 on lung cancer, 1 on breast cancer and 1 on radiotherapy, thus highlighting the wide variety of fields in which the clinical role of BC is under evaluation.